Research programme: heat shock protein 90 inhibitors - TopoTargetAlternative Names: HSP90 inhibitors - TopoTarget
Latest Information Update: 04 Feb 2011
At a glance
- Originator TopoTarget
- Class Small molecules
- Mechanism of Action HSP90 heat-shock protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 04 Sep 2008 Preclinical development is ongoing in Denmark